46 results
DEF 14A
TSBX
Turnstone Biologics Corp
22 Apr 24
Definitive proxy
4:28pm
committee member’s scope of experience and the nature of their prior and/or current employment.
Report of the Audit Committee of the Board … the nature of the amendment or waiver on its website.
Corporate Governance Guidelines
In 2023, the Board documented the governance practices
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
and neck cancer and both cutaneous and non-cutaneous melanomas. We discuss the nature of these investigator-sponsored trials, including how these trials … , and then transferred into the patient. These processes allow for the expansion of T cells away from the immunosuppressive nature of the tumor microenvironment
8-K
EX-99.1
TSBX
Turnstone Biologics Corp
5 Mar 24
Regulation FD Disclosure
8:30am
- Creelan et al; Nature Medicine 2021 Breast Cancer 6† 1 CR, 2 PRs NCI - Zacharakis et al; JCO 2022 Early academic selection strategies1 deployed
10-Q
zhikl0jwikg1ai91 up
1 Sep 23
Quarterly report
4:39pm
8-K
EX-3.2
sii f8ondlu8q6o
25 Jul 23
Amendments to Articles of Incorporation or Bylaws
4:15pm
8-K
EX-3.1
52iibt980bndy2kzu
25 Jul 23
Amendments to Articles of Incorporation or Bylaws
4:15pm
424B4
519nicqc
21 Jul 23
Prospectus supplement with pricing info
7:14pm
CORRESP
uq9mv3y3k y6mv
5 Jul 23
Correspondence with SEC
12:00am
S-1/A
uarfptulvui o6oh
23 Jun 23
IPO registration (amended)
9:49pm
S-1/A
EX-10.6
vit1 2oa5xy
23 Jun 23
IPO registration (amended)
9:49pm
S-1/A
EX-3.4
a0yo tqz6y
23 Jun 23
IPO registration (amended)
9:49pm
S-1/A
EX-3.3
rgrv2z4asyiyi3519x5
23 Jun 23
IPO registration (amended)
9:49pm
CORRESP
g71w2nqvxrmx
23 Jun 23
Correspondence with SEC
12:00am